Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis

Osteoclasts can interact with osteosarcoma to promote the growth of osteosarcoma. Cisplatin is common in adjuvant chemotherapy of osteosarcoma. However, due to chemoresistance, the efficacy is profoundly limited. Previous studies have found that zoledronic acid (ZA) has osteoclast activation inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liang, Geng, Huan, Mei, Chengjie, Chen, Liaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026287/
https://www.ncbi.nlm.nih.gov/pubmed/33859780
http://dx.doi.org/10.1155/2021/6661534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026287/
https://www.ncbi.nlm.nih.gov/pubmed/33859780
http://dx.doi.org/10.1155/2021/6661534

Ejemplares similares